The Patent Finder

Microbiotix, Inc.

2 patents currently held · Updated Nov 21, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

1
Ending by 2030
Jul 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 17, 2027
    The maintenance fee for Inhibitors of bacterial type III secretion system (US 9,340,551) comes due Nov 17, 2027. Unpaid by May 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 2 of 2

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,906,945Inhibitors of bacterial type III secretion system
In force
 · USPTO record
In forceUSPTO record
US 9,340,551Inhibitors of bacterial type III secretion system
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 2: 2 patents in force now held by others · 5 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 1 abandoned · 5 no status recorded

Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/351,961Jul 13, 2023No status recorded
18/840,267Broad Spectrum Inhibitors of CytomegalovirusFeb 22, 2023Pending
17/964,994Metabolically Stable N-Acylaminooxadiazoles Useful as Antibacterial AgentsOct 13, 2022Abandoned
18/272,845Compounds and Methods for Treating MalariaJan 21, 2022Pending
17/085,350Oct 30, 2020No status recorded
17/622,613Compositions and Methods of Treating or Preventing Ocular Infections with FilociclovirJun 24, 2020Pending
17/438,452Mar 12, 2020No status recorded
17/437,236Inhibition of Adenovirus with FilociclovirMar 6, 2020Pending
14/232,520Jul 13, 2012No status recorded
12/991,675May 19, 2009No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited